Ketogenic Diet Interventions in Parkinson's Disease: Safeguarding the Gut Microbiome

NAActive, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

February 28, 2025

Study Completion Date

July 31, 2025

Conditions
Parkinson Disease
Interventions
BEHAVIORAL

Mediterranean-Ketogenic Diet

In the MeDi-KD group, the participants will adhere to a modified Mediterranean-ketogenic diet. The ketogenic component of the diet will require limiting the intake of carbohydrates to about 10% of all calories consumed in a day, while obtaining most of the energy from healthy fats, mostly from plant-based sources (\~70-75% of your daily caloric intake) and lean proteins (\~15-20% of your daily caloric intake). The ketogenic ratio (the ratio of fat to carbohydrates) will be gradually increased during the first week from 1:1 to 3:1. The Mediterranean component of the diet will encourage the participants to consume more green leafy vegetables, nuts, and olive oil, while limiting the consumption of processed or fried food, red meat, full-fat dairy, and sweets.

DIETARY_SUPPLEMENT

Mediterranean diet supplemented with medium-chain triglyceride oil

"The participants will adhere to the Mediterranean diet. In addition, they will be asked to take two daily doses of medium-chain triglyceride oil (MCT oil).~The MCT oil supplement (Nutiva MCT oil, Nutiva Inc.) is approved by Health Canada (NPN: 80086912) and will be used according to its approved condition of use (i.e., source of medium-chain fatty acids which supports energy production in the body at a cellular level \[ATP\]). Each serving of this product provides 130 Calories from MCTs (14 g) with a C8-C10 ratio of 60:40. Nutiva MCT oil can be mixed into any beverage of choice, but cannot be used for cooking.~participants will start the intervention by taking 5 mL of MCT oil twice daily for the first day to acclimate their bodies to the supplement and gradually increase the dose to 14 g BID by the end of week 1. The participants may be asked to increase the dose to 20 mL of MCT twice daily if tolerability remains positive."

Trial Locations (1)

V6T 1Z3

Djawad Mowafaghian Centre for Brain Health, Vancouver

All Listed Sponsors
collaborator

Weston Family Foundation

OTHER

lead

University of British Columbia

OTHER